Showing 2,441 - 2,460 results of 40,084 for search '"The Following"', query time: 0.10s Refine Results
  1. 2441
  2. 2442
  3. 2443
  4. 2444
  5. 2445
  6. 2446
  7. 2447
  8. 2448
  9. 2449
  10. 2450
  11. 2451
  12. 2452
  13. 2453
  14. 2454
  15. 2455

    Progress of research on management of skin graft-versus-host disease following allogeneic hematopoietic stem cell transplantation (异基因造血干细胞移植皮肤急性移植物抗宿主病管理的研究进展) by FU Yuxin (符玉欣), ZHOU Ting (周婷)

    Published 2023-05-01
    “…By reviewing of related studies, this paper summarized pathogenesis, clinical classification, prevention and treatment and nursing measures of acute skin graft-versus-host disease(aGVHD) following allogeneic HSCT, and put forward relevant management advice, in order to provide reference for clinical nurses in the early period of prevention, early detection and timely intervention on aGVHD. …”
    Get full text
    Article
  16. 2456
  17. 2457
  18. 2458
  19. 2459

    Prevalence and risk factors of postpartum depression, general depressive symptoms, anxiety and stress (PODSAS) among mothers during their 4-week postnatal follow-up in five public health clinics in Perak: A study protocol for a cross-sectional study by Boon How Chew, Subashini Ambigapathy, Saidatul Akmar Mohammad Redzuan, Priyasini Suntharalingam, Thenmoli Palaniyappan, Venotha Ganasan, Puteri Normalina Megat Abu Bakar, Paream Kaur, Lili Zuryani Marmuji, V Paranthaman

    Published 2020-06-01
    “…Findings from this study will be used to identify the needs for early screening and detection, encourage development of interventions to reduce its occurrence and support mothers with PODSAS.Methods and analysis This cross-sectional study will recruit 459 postpartum mothers during their 4-week postnatal follow-up in five selected public health clinics in Perak from September 2019 to May 2020. …”
    Get full text
    Article
  20. 2460

    Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study by Alane Izu, Eleanora Aml Mutsaerts, Courtney Olwagen, Lisa Jose, Anthonet Koen, Amit J Nana, Clare L. Cutland, Shabir A. Madhi

    Published 2025-12-01
    “…This study evaluated the immune response at 18 months of age following a 1 + 1 compared to a 2 + 1 schedule of 10-valent (PCV10) and 13-valent (PCV13) vaccines.Research design and methods A single-center, open-label, randomized trial conducted in Soweto, South Africa, evaluated the immunogenicity of differing dosing schedule for PCV10 and PCV13. …”
    Get full text
    Article